BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 82 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $45,000 | -19.6% | 17,033 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $56,000 | -13.8% | 17,033 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $65,000 | +10.2% | 17,033 | +6.2% | 0.01% | 0.0% |
| Q1 2021 | $59,000 | -48.7% | 16,033 | +1.9% | 0.01% | -50.0% |
| Q4 2020 | $115,000 | -22.8% | 15,733 | +16.3% | 0.01% | -48.1% |
| Q3 2020 | $149,000 | -1.3% | 13,533 | 0.0% | 0.03% | -15.6% |
| Q2 2020 | $151,000 | +84.1% | 13,533 | 0.0% | 0.03% | +60.0% |
| Q1 2020 | $82,000 | – | 13,533 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 400,000 | $1,068,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 493,191 | $1,317,000 | 0.07% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $23,000 | 0.00% |
| A.R.T. Advisors, LLC | 22,758 | $60,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,715 | $61,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 1,100 | $3,000 | 0.00% |
| Penserra Capital Management LLC | 4,980 | $13,000 | 0.00% |
| D'Orazio & Associates, Inc. | 500 | $1,000 | 0.00% |
| CITIGROUP INC | 380 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,269 | $163,000 | 0.00% |